 | • レポートコード：QAF27742 • 出版社/出版日：QYResearch / 2021年4月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のイノシンプラノベックス市場について種類別（タブレット、シロップ）、用途別（免疫調節、抗ウイルス、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・イノシンプラノベックス市場の概要 ・世界の主要地域別イノシンプラノベックス市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のイノシンプラノベックス市場規模2016-2021：種類別（タブレット、シロップ） ・世界のイノシンプラノベックス市場予測2012-2027：種類別（タブレット、シロップ） ・世界のイノシンプラノベックス市場規模2016-2021：用途別（免疫調節、抗ウイルス、その他） ・世界のイノシンプラノベックス市場予測2012-2027：用途別（免疫調節、抗ウイルス、その他） ・イノシンプラノベックスのアメリカ市場規模と予測2016-2021 ・イノシンプラノベックスのヨーロッパ市場規模と予測2016-2021 ・イノシンプラノベックスの中国市場規模と予測2016-2021 ・イノシンプラノベックスの日本市場規模と予測2016-2021 ・イノシンプラノベックスの東南アジア市場規模と予測2016-2021 ・イノシンプラノベックスのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Newport Pharmaceuticals、Gedeon Richter、Mochida、Sanofi、Andrómaco、Yung Shin、Alfasigma S.p.A.、Polfarmex、Sanfer、Meprofarm、Novell Pharmaceutical、Aflofarm） ・イノシンプラノベックスの製造コスト分析 ・販売チャネル、流通業者、顧客 ・イノシンプラノベックスの市場動向・機会・課題 ・調査の結論 |
Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.
The classification of Inosine Pranobex includes Tablet, Syrup, the sales of Tablet are 8.45 million units, with its market share 69.3%. And the sales market share of Syrup is 30.7% in 2017.
Market Analysis and Insights: Global Inosine Pranobex Market
The global Inosine Pranobex market was valued at US$ 201.8 in 2020 and will reach US$ 230 million by the end of 2027, growing at a CAGR of 2.2% during 2022-2027.
Global Inosine Pranobex Scope and Market Size
The global Inosine Pranobex market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Inosine Pranobex market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Tablet
Syrup
Segment by Application
Immunomodulation
Antiviral
Other
The Inosine Pranobex market is analysed and market size information is provided by regions (countries). Segment by Application, the Inosine Pranobex market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Newport Pharmaceuticals
Gedeon Richter
Mochida
Sanofi
Andrómaco
Yung Shin
Alfasigma S.p.A.
Polfarmex
Sanfer
Meprofarm
Novell Pharmaceutical
Aflofarm
1 Inosine Pranobex Market Overview
1.1 Inosine Pranobex Product Scope
1.2 Inosine Pranobex Segment by Type
1.2.1 Global Inosine Pranobex Sales by Type (2016 & 2021 & 2027)
1.2.2 Tablet
1.2.3 Syrup
1.3 Inosine Pranobex Segment by Application
1.3.1 Global Inosine Pranobex Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Immunomodulation
1.3.3 Antiviral
1.3.4 Other
1.4 Inosine Pranobex Market Estimates and Forecasts (2016-2027)
1.4.1 Global Inosine Pranobex Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Inosine Pranobex Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Inosine Pranobex Price Trends (2016-2027)
2 Inosine Pranobex Estimates and Forecasts by Region
2.1 Global Inosine Pranobex Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Inosine Pranobex Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Inosine Pranobex Sales Market Share by Region (2016-2021)
2.2.2 Global Inosine Pranobex Revenue Market Share by Region (2016-2021)
2.3 Global Inosine Pranobex Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Inosine Pranobex Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Inosine Pranobex Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Inosine Pranobex Estimates and Projections (2016-2027)
2.4.2 Europe Inosine Pranobex Estimates and Projections (2016-2027)
2.4.3 China Inosine Pranobex Estimates and Projections (2016-2027)
2.4.4 Japan Inosine Pranobex Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Inosine Pranobex Estimates and Projections (2016-2027)
2.4.6 India Inosine Pranobex Estimates and Projections (2016-2027)
3 Global Inosine Pranobex Competition Landscape by Players
3.1 Global Top Inosine Pranobex Players by Sales (2016-2021)
3.2 Global Top Inosine Pranobex Players by Revenue (2016-2021)
3.3 Global Inosine Pranobex Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inosine Pranobex as of 2020)
3.4 Global Inosine Pranobex Average Price by Company (2016-2021)
3.5 Manufacturers Inosine Pranobex Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Inosine Pranobex Market Size by Type
4.1 Global Inosine Pranobex Historic Market Review by Type (2016-2021)
4.1.1 Global Inosine Pranobex Sales Market Share by Type (2016-2021)
4.1.2 Global Inosine Pranobex Revenue Market Share by Type (2016-2021)
4.1.3 Global Inosine Pranobex Price by Type (2016-2021)
4.2 Global Inosine Pranobex Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Inosine Pranobex Sales Forecast by Type (2022-2027)
4.2.2 Global Inosine Pranobex Revenue Forecast by Type (2022-2027)
4.2.3 Global Inosine Pranobex Price Forecast by Type (2022-2027)
5 Global Inosine Pranobex Market Size by Application
5.1 Global Inosine Pranobex Historic Market Review by Application (2016-2021)
5.1.1 Global Inosine Pranobex Sales Market Share by Application (2016-2021)
5.1.2 Global Inosine Pranobex Revenue Market Share by Application (2016-2021)
5.1.3 Global Inosine Pranobex Price by Application (2016-2021)
5.2 Global Inosine Pranobex Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Inosine Pranobex Sales Forecast by Application (2022-2027)
5.2.2 Global Inosine Pranobex Revenue Forecast by Application (2022-2027)
5.2.3 Global Inosine Pranobex Price Forecast by Application (2022-2027)
6 North America Inosine Pranobex Market Facts & Figures
6.1 North America Inosine Pranobex Sales by Company
6.1.1 North America Inosine Pranobex Sales by Company (2016-2021)
6.1.2 North America Inosine Pranobex Revenue by Company (2016-2021)
6.2 North America Inosine Pranobex Sales Breakdown by Type
6.2.1 North America Inosine Pranobex Sales Breakdown by Type (2016-2021)
6.2.2 North America Inosine Pranobex Sales Breakdown by Type (2022-2027)
6.3 North America Inosine Pranobex Sales Breakdown by Application
6.3.1 North America Inosine Pranobex Sales Breakdown by Application (2016-2021)
6.3.2 North America Inosine Pranobex Sales Breakdown by Application (2022-2027)
7 Europe Inosine Pranobex Market Facts & Figures
7.1 Europe Inosine Pranobex Sales by Company
7.1.1 Europe Inosine Pranobex Sales by Company (2016-2021)
7.1.2 Europe Inosine Pranobex Revenue by Company (2016-2021)
7.2 Europe Inosine Pranobex Sales Breakdown by Type
7.2.1 Europe Inosine Pranobex Sales Breakdown by Type (2016-2021)
7.2.2 Europe Inosine Pranobex Sales Breakdown by Type (2022-2027)
7.3 Europe Inosine Pranobex Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China Inosine Pranobex Market Facts & Figures
8.1 China Inosine Pranobex Sales by Company
8.1.1 China Inosine Pranobex Sales by Company (2016-2021)
8.1.2 China Inosine Pranobex Revenue by Company (2016-2021)
8.2 China Inosine Pranobex Sales Breakdown by Type
8.2.1 China Inosine Pranobex Sales Breakdown by Type (2016-2021)
8.2.2 China Inosine Pranobex Sales Breakdown by Type (2022-2027)
8.3 China Inosine Pranobex Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Inosine Pranobex Market Facts & Figures
9.1 Japan Inosine Pranobex Sales by Company
9.1.1 Japan Inosine Pranobex Sales by Company (2016-2021)
9.1.2 Japan Inosine Pranobex Revenue by Company (2016-2021)
9.2 Japan Inosine Pranobex Sales Breakdown by Type
9.2.1 Japan Inosine Pranobex Sales Breakdown by Type (2016-2021)
9.2.2 Japan Inosine Pranobex Sales Breakdown by Type (2022-2027)
9.3 Japan Inosine Pranobex Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Inosine Pranobex Market Facts & Figures
10.1 Southeast Asia Inosine Pranobex Sales by Company
10.1.1 Southeast Asia Inosine Pranobex Sales by Company (2016-2021)
10.1.2 Southeast Asia Inosine Pranobex Revenue by Company (2016-2021)
10.2 Southeast Asia Inosine Pranobex Sales Breakdown by Type
10.2.1 Southeast Asia Inosine Pranobex Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Inosine Pranobex Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Inosine Pranobex Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Inosine Pranobex Market Facts & Figures
11.1 India Inosine Pranobex Sales by Company
11.1.1 India Inosine Pranobex Sales by Company (2016-2021)
11.1.2 India Inosine Pranobex Revenue by Company (2016-2021)
11.2 India Inosine Pranobex Sales Breakdown by Type
11.2.1 India Inosine Pranobex Sales Breakdown by Type (2016-2021)
11.2.2 India Inosine Pranobex Sales Breakdown by Type (2022-2027)
11.3 India Inosine Pranobex Sales Breakdown by Application
11.3.1 India Inosine Pranobex Sales Breakdown by Application (2016-2021)
11.3.2 India Inosine Pranobex Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Inosine Pranobex Business
12.1 Newport Pharmaceuticals
12.1.1 Newport Pharmaceuticals Corporation Information
12.1.2 Newport Pharmaceuticals Business Overview
12.1.3 Newport Pharmaceuticals Inosine Pranobex Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Newport Pharmaceuticals Inosine Pranobex Products Offered
12.1.5 Newport Pharmaceuticals Recent Development
12.2 Gedeon Richter
12.2.1 Gedeon Richter Corporation Information
12.2.2 Gedeon Richter Business Overview
12.2.3 Gedeon Richter Inosine Pranobex Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Gedeon Richter Inosine Pranobex Products Offered
12.2.5 Gedeon Richter Recent Development
12.3 Mochida
12.3.1 Mochida Corporation Information
12.3.2 Mochida Business Overview
12.3.3 Mochida Inosine Pranobex Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mochida Inosine Pranobex Products Offered
12.3.5 Mochida Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Business Overview
12.4.3 Sanofi Inosine Pranobex Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi Inosine Pranobex Products Offered
12.4.5 Sanofi Recent Development
12.5 Andrómaco
12.5.1 Andrómaco Corporation Information
12.5.2 Andrómaco Business Overview
12.5.3 Andrómaco Inosine Pranobex Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Andrómaco Inosine Pranobex Products Offered
12.5.5 Andrómaco Recent Development
12.6 Yung Shin
12.6.1 Yung Shin Corporation Information
12.6.2 Yung Shin Business Overview
12.6.3 Yung Shin Inosine Pranobex Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Yung Shin Inosine Pranobex Products Offered
12.6.5 Yung Shin Recent Development
12.7 Alfasigma S.p.A.
12.7.1 Alfasigma S.p.A. Corporation Information
12.7.2 Alfasigma S.p.A. Business Overview
12.7.3 Alfasigma S.p.A. Inosine Pranobex Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Alfasigma S.p.A. Inosine Pranobex Products Offered
12.7.5 Alfasigma S.p.A. Recent Development
12.8 Polfarmex
12.8.1 Polfarmex Corporation Information
12.8.2 Polfarmex Business Overview
12.8.3 Polfarmex Inosine Pranobex Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Polfarmex Inosine Pranobex Products Offered
12.8.5 Polfarmex Recent Development
12.9 Sanfer
12.9.1 Sanfer Corporation Information
12.9.2 Sanfer Business Overview
12.9.3 Sanfer Inosine Pranobex Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sanfer Inosine Pranobex Products Offered
12.9.5 Sanfer Recent Development
12.10 Meprofarm
12.10.1 Meprofarm Corporation Information
12.10.2 Meprofarm Business Overview
12.10.3 Meprofarm Inosine Pranobex Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Meprofarm Inosine Pranobex Products Offered
12.10.5 Meprofarm Recent Development
12.11 Novell Pharmaceutical
12.11.1 Novell Pharmaceutical Corporation Information
12.11.2 Novell Pharmaceutical Business Overview
12.11.3 Novell Pharmaceutical Inosine Pranobex Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novell Pharmaceutical Inosine Pranobex Products Offered
12.11.5 Novell Pharmaceutical Recent Development
12.12 Aflofarm
12.12.1 Aflofarm Corporation Information
12.12.2 Aflofarm Business Overview
12.12.3 Aflofarm Inosine Pranobex Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Aflofarm Inosine Pranobex Products Offered
12.12.5 Aflofarm Recent Development
13 Inosine Pranobex Manufacturing Cost Analysis
13.1 Inosine Pranobex Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Inosine Pranobex
13.4 Inosine Pranobex Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Inosine Pranobex Distributors List
14.3 Inosine Pranobex Customers
15 Market Dynamics
15.1 Inosine Pranobex Market Trends
15.2 Inosine Pranobex Drivers
15.3 Inosine Pranobex Market Challenges
15.4 Inosine Pranobex Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Inosine Pranobex Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Inosine Pranobex Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Inosine Pranobex Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Inosine Pranobex Sales (K Units) by Region (2016-2021)
Table 5. Global Inosine Pranobex Sales Market Share by Region (2016-2021)
Table 6. Global Inosine Pranobex Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Inosine Pranobex Revenue Share by Region (2016-2021)
Table 8. Global Inosine Pranobex Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Inosine Pranobex Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Inosine Pranobex Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Inosine Pranobex Revenue Share Forecast by Region (2022-2027)
Table 12. Global Inosine Pranobex Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Inosine Pranobex Sales Share by Company (2016-2021)
Table 14. Global Inosine Pranobex Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Inosine Pranobex Revenue Share by Company (2016-2021)
Table 16. Global Inosine Pranobex by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inosine Pranobex as of 2020)
Table 17. Global Inosine Pranobex Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Inosine Pranobex Manufacturing Sites and Area Served
Table 19. Manufacturers Inosine Pranobex Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Inosine Pranobex Sales (K Units) by Type (2016-2021)
Table 22. Global Inosine Pranobex Sales Share by Type (2016-2021)
Table 23. Global Inosine Pranobex Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Inosine Pranobex Price (USD/Unit) by Type (2016-2021)
Table 25. Global Inosine Pranobex Sales Share by Type (2022-2027)
Table 26. Global Inosine Pranobex Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Inosine Pranobex Revenue Share by Type (2022-2027)
Table 28. Global Inosine Pranobex Price (USD/Unit) by Type (2022-2027)
Table 29. Global Inosine Pranobex Sales (K Units) by Application (2016-2021)
Table 30. Global Inosine Pranobex Sales Share by Application (2016-2021)
Table 31. Global Inosine Pranobex Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Inosine Pranobex Price (USD/Unit) by Application (2016-2021)
Table 33. Global Inosine Pranobex Sales (K Units) by Application (2022-2027)
Table 34. Global Inosine Pranobex Sales Share by Application (2022-2027)
Table 35. Global Inosine Pranobex Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Inosine Pranobex Revenue Share by Application (2022-2027)
Table 37. Global Inosine Pranobex Price (USD/Unit) by Application (2022-2027)
Table 38. North America Inosine Pranobex Sales (K Units) by Company (2016-2021)
Table 39. North America Inosine Pranobex Sales Market Share by Company (2016-2021)
Table 40. North America Inosine Pranobex Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Inosine Pranobex Revenue Market Share by Company (2016-2021)
Table 42. North America Inosine Pranobex Sales by Type (2016-2021) & (K Units)
Table 43. North America Inosine Pranobex Sales Market Share by Type (2016-2021)
Table 44. North America Inosine Pranobex Sales by Type (2022-2027) & (K Units)
Table 45. North America Inosine Pranobex Sales Market Share by Type (2022-2027)
Table 46. North America Inosine Pranobex Sales by Application (2016-2021) & (K Units)
Table 47. North America Inosine Pranobex Sales Market Share by Application (2016-2021)
Table 48. North America Inosine Pranobex Sales by Application (2022-2027) & (K Units)
Table 49. North America Inosine Pranobex Sales Market Share by Application (2022-2027)
Table 50. Europe Inosine Pranobex Sales (K Units) by Company (2016-2021)
Table 51. Europe Inosine Pranobex Sales Market Share by Company (2016-2021)
Table 52. Europe Inosine Pranobex Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Inosine Pranobex Revenue Market Share by Company (2016-2021)
Table 54. Europe Inosine Pranobex Sales by Type (2016-2021) & (K Units)
Table 55. Europe Inosine Pranobex Sales Market Share by Type (2016-2021)
Table 56. Europe Inosine Pranobex Sales by Type (2022-2027) & (K Units)
Table 57. Europe Inosine Pranobex Sales Market Share by Type (2022-2027)
Table 58. Europe Inosine Pranobex Sales by Application (2016-2021) & (K Units)
Table 59. Europe Inosine Pranobex Sales Market Share by Application (2016-2021)
Table 60. Europe Inosine Pranobex Sales by Application (2022-2027) & (K Units)
Table 61. Europe Inosine Pranobex Sales Market Share by Application (2022-2027)
Table 62. China Inosine Pranobex Sales (K Units) by Company (2016-2021)
Table 63. China Inosine Pranobex Sales Market Share by Company (2016-2021)
Table 64. China Inosine Pranobex Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Inosine Pranobex Revenue Market Share by Company (2016-2021)
Table 66. China Inosine Pranobex Sales by Type (2016-2021) & (K Units)
Table 67. China Inosine Pranobex Sales Market Share by Type (2016-2021)
Table 68. China Inosine Pranobex Sales by Type (2022-2027) & (K Units)
Table 69. China Inosine Pranobex Sales Market Share by Type (2022-2027)
Table 70. China Inosine Pranobex Sales by Application (2016-2021) & (K Units)
Table 71. China Inosine Pranobex Sales Market Share by Application (2016-2021)
Table 72. China Inosine Pranobex Sales by Application (2022-2027) & (K Units)
Table 73. China Inosine Pranobex Sales Market Share by Application (2022-2027)
Table 74. Japan Inosine Pranobex Sales (K Units) by Company (2016-2021)
Table 75. Japan Inosine Pranobex Sales Market Share by Company (2016-2021)
Table 76. Japan Inosine Pranobex Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Inosine Pranobex Revenue Market Share by Company (2016-2021)
Table 78. Japan Inosine Pranobex Sales by Type (2016-2021) & (K Units)
Table 79. Japan Inosine Pranobex Sales Market Share by Type (2016-2021)
Table 80. Japan Inosine Pranobex Sales by Type (2022-2027) & (K Units)
Table 81. Japan Inosine Pranobex Sales Market Share by Type (2022-2027)
Table 82. Japan Inosine Pranobex Sales by Application (2016-2021) & (K Units)
Table 83. Japan Inosine Pranobex Sales Market Share by Application (2016-2021)
Table 84. Japan Inosine Pranobex Sales by Application (2022-2027) & (K Units)
Table 85. Japan Inosine Pranobex Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Inosine Pranobex Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Inosine Pranobex Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Inosine Pranobex Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Inosine Pranobex Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Inosine Pranobex Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Inosine Pranobex Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Inosine Pranobex Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Inosine Pranobex Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Inosine Pranobex Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Inosine Pranobex Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Inosine Pranobex Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Inosine Pranobex Sales Market Share by Application (2022-2027)
Table 98. India Inosine Pranobex Sales (K Units) by Company (2016-2021)
Table 99. India Inosine Pranobex Sales Market Share by Company (2016-2021)
Table 100. India Inosine Pranobex Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Inosine Pranobex Revenue Market Share by Company (2016-2021)
Table 102. India Inosine Pranobex Sales by Type (2016-2021) & (K Units)
Table 103. India Inosine Pranobex Sales Market Share by Type (2016-2021)
Table 104. India Inosine Pranobex Sales by Type (2022-2027) & (K Units)
Table 105. India Inosine Pranobex Sales Market Share by Type (2022-2027)
Table 106. India Inosine Pranobex Sales by Application (2016-2021) & (K Units)
Table 107. India Inosine Pranobex Sales Market Share by Application (2016-2021)
Table 108. India Inosine Pranobex Sales by Application (2022-2027) & (K Units)
Table 109. India Inosine Pranobex Sales Market Share by Application (2022-2027)
Table 110. Newport Pharmaceuticals Corporation Information
Table 111. Newport Pharmaceuticals Description and Business Overview
Table 112. Newport Pharmaceuticals Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Newport Pharmaceuticals Inosine Pranobex Product
Table 114. Newport Pharmaceuticals Recent Development
Table 115. Gedeon Richter Corporation Information
Table 116. Gedeon Richter Description and Business Overview
Table 117. Gedeon Richter Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Gedeon Richter Inosine Pranobex Product
Table 119. Gedeon Richter Recent Development
Table 120. Mochida Corporation Information
Table 121. Mochida Description and Business Overview
Table 122. Mochida Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Mochida Inosine Pranobex Product
Table 124. Mochida Recent Development
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Sanofi Inosine Pranobex Product
Table 129. Sanofi Recent Development
Table 130. Andrómaco Corporation Information
Table 131. Andrómaco Description and Business Overview
Table 132. Andrómaco Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Andrómaco Inosine Pranobex Product
Table 134. Andrómaco Recent Development
Table 135. Yung Shin Corporation Information
Table 136. Yung Shin Description and Business Overview
Table 137. Yung Shin Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Yung Shin Inosine Pranobex Product
Table 139. Yung Shin Recent Development
Table 140. Alfasigma S.p.A. Corporation Information
Table 141. Alfasigma S.p.A. Description and Business Overview
Table 142. Alfasigma S.p.A. Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Alfasigma S.p.A. Inosine Pranobex Product
Table 144. Alfasigma S.p.A. Recent Development
Table 145. Polfarmex Corporation Information
Table 146. Polfarmex Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Polfarmex Description and Business Overview
Table 148. Polfarmex Inosine Pranobex Product
Table 149. Polfarmex Recent Development
Table 150. Sanfer Corporation Information
Table 151. Sanfer Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Sanfer Description and Business Overview
Table 153. Sanfer Inosine Pranobex Product
Table 154. Sanfer Recent Development
Table 155. Meprofarm Corporation Information
Table 156. Meprofarm Description and Business Overview
Table 157. Meprofarm Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Meprofarm Inosine Pranobex Product
Table 159. Meprofarm Recent Development
Table 160. Novell Pharmaceutical Corporation Information
Table 161. Novell Pharmaceutical Description and Business Overview
Table 162. Novell Pharmaceutical Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Novell Pharmaceutical Inosine Pranobex Product
Table 164. Novell Pharmaceutical Recent Development
Table 165. Aflofarm Corporation Information
Table 166. Aflofarm Description and Business Overview
Table 167. Aflofarm Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Aflofarm Inosine Pranobex Product
Table 169. Aflofarm Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Inosine Pranobex Distributors List
Table 173. Inosine Pranobex Customers List
Table 174. Inosine Pranobex Market Trends
Table 175. Inosine Pranobex Market Drivers
Table 176. Inosine Pranobex Market Challenges
Table 177. Inosine Pranobex Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Inosine Pranobex Product Picture
Figure 2. Global Inosine Pranobex Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Inosine Pranobex Sales Market Share by Application in 2021 & 2027
Figure 6. Immunomodulation Examples
Figure 7. Antiviral Examples
Figure 8. Other Examples
Figure 9. Global Inosine Pranobex Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Inosine Pranobex Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Inosine Pranobex Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Inosine Pranobex Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Inosine Pranobex Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Inosine Pranobex Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Inosine Pranobex Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Inosine Pranobex Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Inosine Pranobex Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Inosine Pranobex Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Inosine Pranobex Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Inosine Pranobex Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Inosine Pranobex Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Inosine Pranobex Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Inosine Pranobex Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Inosine Pranobex Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Inosine Pranobex Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Inosine Pranobex Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Inosine Pranobex Players Market Share by Revenue in Inosine Pranobex: 2016 & 2020
Figure 28. Inosine Pranobex Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Inosine Pranobex Revenue Share by Type (2016-2021)
Figure 30. Global Inosine Pranobex Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Inosine Pranobex Revenue Share by Application (2016-2021)
Figure 32. Global Inosine Pranobex Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Inosine Pranobex Sales Market Share by Type in 2020
Figure 34. North America Inosine Pranobex Sales Market Share by Application in 2020
Figure 35. Europe Inosine Pranobex Sales Market Share by Type in 2020
Figure 36. Europe Inosine Pranobex Sales Market Share by Application in 2020
Figure 37. China Inosine Pranobex Sales Market Share by Type in 2020
Figure 38. China Inosine Pranobex Sales Market Share by Application in 2020
Figure 39. Japan Inosine Pranobex Sales Market Share by Type in 2020
Figure 40. Japan Inosine Pranobex Sales Market Share by Application in 2020
Figure 41. Southeast Asia Inosine Pranobex Sales Market Share by Type in 2020
Figure 42. Southeast Asia Inosine Pranobex Sales Market Share by Application in 2020
Figure 43. India Inosine Pranobex Sales Market Share by Type in 2020
Figure 44. India Inosine Pranobex Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Inosine Pranobex
Figure 47. Manufacturing Process Analysis of Inosine Pranobex
Figure 48. Inosine Pranobex Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
高果糖コーンシロップのグローバル市場2021 In terms of composition, high fructose corn syrup is nearly identical to table sugar (sucrose), which is composed of 50 percent fructose and 50 percent glucose. Glucose is one of the simplest forms of sugar that serves as a building block for most carbohydrates. Fructose is a simple sugar commonly f…- ペンタブレットのグローバル市場2021 A pen tablet (also known as a digitizer, drawing tablet, digital drawing tablet, graphic tablet, or digital art board) is a computer input device that enables a user to hand-draw images, animations and graphics, with a special pen-like stylus, similar to the way a person draws images with a pencil a…
- 世界の抗ウイルス経口液市場規模・現状・予測（2021年-2027年） Antiviral Oral liquids are homogeneous liquid preparations, usually contains a solution, an emulsion or a suspension of one or more active ingredients in a suitable liquid base. Market Analysis and Insights: Global Antiviral Oral Liquid Market The global Antiviral Oral Liquid market size is projecte…
- 世界の抗ウイルス療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Antiviral Therapeutics Market The global Antiviral Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…
- アルテスネイト錠剤のグローバル市場2021 Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria. The classification of Artesunate Tablet includes Monoaromatic Artesunate and Compou…